To investigate the long-term efficacy of irradiated recombinant human osteogenic protein 1 (hOP-1) in bone regeneration and morphogenesis, hOP-1 was combined with a bovine collagenous matrix carrier (0, 0.1, 0.5, and 2.5 mg hOP-1/g of matrix), sterilized with 2.5 Mrads of ␥-irradiation, and implanted in 80 calvarial defects in 20 adult baboons (Papio ursinus). The relative efficacy of partially purified bone-derived baboon bone morphogenetic proteins (BMPs), known to contain several osteogenic proteins, was compared with the recombinant hOP-1 device in an additional four baboons. Histology and histomorphometry on serial undecalcified sections prepared from the specimens harvested on day 90 and day 365 showed that ␥-irradiated hOP-1 devices induced regeneration of the calvarial defects by day 90, although with reduced bone area compared with a previous published series of calvarial defects treated with nonirradiated hOP-1 devices. One year after application of the irradiated hOP-1 devices, bone and osteoid volumes and generated bone tissue areas were comparable with nonirradiated hOP-1 specimens. Moreover, 365 days after healing regenerates induced by 0.5 mg and 2.5 mg of irradiated hOP-1 devices showed greater amounts of bone and osteoid volumes when compared with those induced by nonirradiated hOP-1 devices. On day 90, defects treated with 0.1 mg and 0.5 mg of bone-derived baboon BMPs, combined with irradiated matrix, showed significantly less bone compared with defects receiving irradiated devices containing 0.1 mg and 0.5 mg hOP-1; 2.5 mg of partially purified BMPs induced bone and osteoid volumes comparable with the 0.1-mg and 0.5-mg hOP-1 devices. Control specimens of ␥-irradiated collagenous matrix without hOP-1 displayed a nearly 2-fold reduction in osteoconductive bone repair when compared with nonirradiated controls. These findings suggest that the reduction in bone volume and bone tissue area on day 90 may be caused by a reduced performance of the irradiated collagenous matrix substratum rather than to a reduction in the biological activity of the 
INTRODUCTION

B
ONE REGENERATION in clinical contexts requires three key components: an osteoinductive signal; an insoluble substratum, which delivers the signal and acts as a scaffold for new bone formation; and host cells capable of differentiation into bone cells in response to the osteoinductive signal. The signals responsible for osteoinduction are conferred by the family of the bone morphogenetic proteins (BMPs). BMPs are members of a superfamily of morphogens that include the transforming growth factor ␤s (TGF-␤s), the growth/differentiating factors (GDFs), and cartilage-derived morphogenetic proteins (CDMPs). (1) (2) (3) (4) (5) (6) In addition, the BMPs show significant amino acid identities with developmentally critical regulatory genes such as decapentaplegic (DPP) and 60A in Drosophila, Vegetal (Vg-1) in Xenopus and activins and inhibins. (1) (2) (3) (4) A striking and discriminating feature of BMPs is their ability to induce de novo cartilage and bone formation in extraskeletal (heterotopic) sites, recapitulating embryonic bone development. (1) (2) (3) (4) Originally, the osteogenic potential of BMPs was shown by reconstituting dissociatively extracted demineralized bone matrix with purified solubilized proteins. (7) This was followed by molecular cloning and expression of several recombinant human BMPs (BMP-2 to BMP-6, osteogenic protein 1 [OP-1] and OP-2. (8 -11) Recombinant human BMP-2, BMP-4, and OP-1 (BMP-7) singly initiate endochondral bone formation in the subcutaneous space of the rat when combined with insoluble collagenous bone matrix, the inactive residue obtained after dissociative extraction of bone matrix with 4 M guanidinium-HCl. (12) (13) (14) In addition to BMPs/OPs, other related signaling proteins display heterotopic bone inductive activities in the rodent subcutaneous assay, including recombinantly produced DPP and 60A, (15) gene products expressed early in Drosophila development, and GDF-5 (CDMP-1), (16) a BMP/OP-related protein that may be critical during skeletogenesis, as suggested by mutations of the GDF-5 gene in brachypodism affected mice (17) and humans. (18) The presence of several related but different BMPs with osteogenic activity points to multiple interactions during both embryonic development and bone regeneration in postnatal life. The fact that a single BMP/OP initiates bone formation does not preclude the requirement and interactions of other morphogens deployed synchronously and sequentially during the cascade of bone formation by induction. (1) (2) (3) (4) The apparent redundancy of BMP/OP family members may have biological and therapeutic relevance in bone induction, which may proceed via the combined action of several BMPs/OPs, resident within the natural milieu of the extracellular matrix of bone.
The necessity of the insoluble substratum (collagenous matrix) in the induction of tissue morphogenesis and regeneration by an osteogenic signal (BMPs/OPs) illustrates the critical importance of the extracellular matrix for cell recruitment, attachment, proliferation, and differentiation. (1, 3, 7) Although the therapeutic use of recombinant BMPs/OPs requires sterilization of both soluble signal and insoluble substratum combined to produce an osteogenic device, comprehensive studies on the therapeutic efficacy of bone formation by irradiated osteogenic proteins and irradiated matrices are lacking. Here we report on the characterization and biological activity of hOP-1 after irradiation and on the long-term evaluation of bone regeneration by the irradiated hOP-1 device in calvarial defects of adult baboons. Moreover, we compared the relative inductive efficacy of partially purified baboon BMPs, known to contain several BMPs/OPs in addition to as yet poorly characterized mitogens, with the regenerates induced by the single and recombinant hOP-1 device in the same primate model.
MATERIALS AND METHODS
Preparation of the osteogenic devices
Mature recombinant human OP-1 is a glycosylated 36-kDa homodimer of 139 amino acid residue chains. Stock solutions of hOP-1 were prepared in 50% ethanol, 0.01% trifluoroacetic acid, and protein concentration determined by absorbance readings at 280 nm using an extinction coefficient of 2.0 for a 1.0-mg/ml solution. Demineralized bone matrix, prepared from diaphyseal segments of bovine cortical bones, was dissociatively extracted in 4 M guanidinium-HCl (7) and the resulting inactive insoluble collagenous matrix was treated with 0.1 M acetic acid at 55°C for 1 h, washed with distilled water, and dried. Aliquots of carrier matrix (1 g) were combined with 0.1, 0.5, and 2.5 mg of hOP-1 and lyophilized to produce the hOP-1 device. Bovine collagenous matrix was prepared with liquid vehicle without hOP-1, lyophilized, and used as control. The hOP-1 devices were packaged in borosilicate glass vials and sealed under vacuum. The devices were then sterilized at ambient temperature with ␥-radiation (Cobalt-60 source) using an irradiation dose of approximately 0.3 Mrads/h for a total of 2.5-3.0 Mrads. The irradiation was performed at a contract facility (Isomedix, Northborough, MA, U.S.A., or Radiation Technologies, Inc., NJ, U.S.A.). This dose of irradiation was selected because 2.5 Mrads is accepted by the medical device industry and the Food and Drug Administration (Rockville, MD, U.S.A.) as the minimum required dose to sterilize med-
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ical supplies. (19 -21) For this collagen-based device, 1.5 Mrads was determined to be the minimum dose required to achieve a 10 Ϫ6 sterility assurance level. (22) In addition to inactivating bacteria, 2.5 Mrads ␥-irradiation has been shown to reduce viral titers by 3-5 logs using model virus systems. (23) Baboon acid-demineralized bone matrix was extracted in 4 M guanidinium-HCl, (7) and partial purification was achieved by sequential chromatography of the protein extract on heparin-Sepharose, hydroxyapatite, and Sephacryl S-200 columns, washed and eluted as described. (19, 20) To increase specific osteogenic activity of the preparation, Sephacryl S-200 fractions were chromatographed on a second heparinSepharose affinity column (20-ml bed volume). The recovered 500-mM NaCl step-eluted fraction was concentrated, exchanged with 5 mM HCl to a final concentration of 1 mg/ml protein (7.5 mg total amount), and sterilized by filtration (0.22 m; Millex; Millipore Corp., Bedford, MA, U.S.A.). Aliquots were combined with 25 mg of rat insoluble collagenous matrix and assayed for osteogenic activity in the subcutaneous space of the rat as described. (24 -26) Implants were harvested on day 12 and osteogenic activity in the rat was assessed by measuring alkaline phosphatase activity, calcium content, and histology. For preparation of devices, bone-derived BMPs in 500 l of 5 mM HCl were added to 1 g of irradiated bovine collagenous matrix per sample at doses of 0.1 (n ϭ 4), 0.5 (n ϭ 4), and 2.5 mg (n ϭ 2) and lyophilized.
Characterization and biological activity of hOP-1 device after ␥-irradiation
To determine the recovery of the recombinant morphogen from the collagenous matrix, hOP-1 was eluted from the matrix with 8 M urea buffer, and the integrity and yield of the recovered protein was assessed by reversed-phase highperformance liquid chromatography (rpHPLC) in acetonitrile gradient. The recovered hOP-1 also was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblot analysis using antibodies specific for hOP-1. (27) The biological activity of the proteins recovered from ␥-irradiated and nonirradiated collagenous matrices was assayed using rat osteosarcoma (ROS) 17/2.8 cells cultured as described. (28) The alkaline phosphatase activity induced by hOP-1 recovered from irradiated and nonirradiated devices was compared with the activity induced by an hOP-1 standard. (14, 28) To assess the in vivo osteogenic activity of the hOP-1 device after ␥-irradiation, 3 doses of OP-1 (0.5, 1, and 2.5 g) were combined with 25 mg of bovine collagenous matrix as carrier and sterilized with 2.5 Mrads of ␥-irradiation. The pellets were implanted in the subcutaneous space of LongEvans rats at bilateral sites over the pectoralis fascia. (14, 26) Nonirradiated hOP-1 devices were used as positive controls. Implants were harvested on day 12 and assayed for tissue alkaline phosphatase activity, calcium content, and histology. (14, 26) 
Primate model for tissue induction
Twenty-four clinically healthy adult Chacma baboons (Papio ursinus), with a mean weight of 34.8 Ϯ 3.1 kg, were selected from the primate colony of the University of the Witwatersrand, Johannesburg. Comparative histomorphometric studies between iliac crest biopsy specimens of humans and Papio ursinus showed a remarkable degree of similarity. (29) This makes the adult male baboon ideally suited for the study of comparative bone physiology and repair with relevance to man. (29) Criteria for selection, housing conditions and diet were as described. (30) Research protocols were approved by the Animal Ethics Screening Committee of the university, and conducted according to the Guidelines for the Care and Use of Experimental Animals prepared by the university, and in compliance with the National Code for Animal Use in Research, Education and Diagnosis in South Africa. (31) The orthotopic calvarial model in the baboon has been described in detail. a The 2.5 mg of recombinant hOP-1 was combined with 1 g of bovine collagenous matrix and sterilized with 2.5 Mrads of ␥-irradiation. The recombinant protein was eluted from irradiated and nonirradiated hOP-1 devices with 8 M urea buffer and analyzed by rpHPLC as described in the Materials and Methods section. Determinations were done in triplicate and are expressed as mean and SD.
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each side of the calvaria, two full thickness defects, 25 mm in diameter, were created with a craniotome under saline irrigation. (32) (33) (34) After determination of the structural integrity and biological activity of the ␥-irradiated hOP-1, a block design was used to allocate the position of the irradiated hOP-1 device in 80 calvarial defects in 20 adult male baboons (Fig. 1A) . In each animal, three defects were implanted with an identical dose of hOP-1 in conjunction with the collagenous matrix as carrier. The remaining defect was left untreated, to determine whether hOP-1 had the ability to influence the untreated calvarial site at a distance from implantation. Thus, 15 defects in 5 baboons were implanted with 0.1 mg hOP-1, 15 defects with 0.5 mg hOP-1 and 15 defects with 2.5 mg hOP-1/g of collagenous matrix as carrier. In addition, 15 defects in 5 baboons were implanted with irradiated collagenous matrix without hOP-1 as control. To determine the relative efficacy of bone-derived partially purified baboon BMPs delivered by irradiated bovine collagenous matrix, experiments were performed in the remaining 4 baboons with a modified implantation design (Fig. 1B) in that in each animal, the two ipsilateral defects were implanted with doses of bone-derived BMPs (0.1, 0.5, and 2.5 mg/g of irradiated bovine collagenous matrix). Remaining defects (n ϭ 6) were implanted with 0.1 mg and 0.5 mg of irradiated hOP-1 per device.
Tissue harvest, histology, and histomorphometry
Anesthetized animals were killed with an intravenous overdose of sodium pentobarbitone, 16 animals on day 90 and 8 animals on day 365 after surgery. Bilateral carotid perfusion and harvest of specimens with surrounding calvaria were as described. (32) (33) (34) Specimen blocks were cut along the sagittal one-fourth of the implanted defects, dehydrated in ascending grades of ethanol, and embedded, undecalcified, in a polymethyl methacrylate resin (K-Plast; Medim, Buseck, Germany). Undecalcified serial sections, cut at 7 m (Polycut-S; Reichert, Heidelberg, Germany), were stained, free-floating, with Goldner's trichrome or with 0.1% toluidine blue in 30% ethanol. Goldner's trichrome-stained sections were examined with a Provis AX70 research microscope (Olympus Optical Co., Japan) equipped with a calibrated Zeiss Integration Platte II (Oberkochem, Germany) with 100 lattice points for determination by the point-counting technique, (35) of mineralized bone, osteoid, and residual collagenous matrix volumes (in %). Sections were analyzed at 40ϫ, superimposing the Zeiss graticule over five sources (36) selected for histomorphometry and defined as follows: two anterior and posterior interfacial regions (AIF and PIF), two anterior and posterior internal regions (AIN and PIN), and a central region (CEN). (32) (33) (34) This technique allows the histomorphometric evaluation of the distribution of bone regeneration across 
FIG. 3.
Stimulation of alkaline phosphatase activity in ROS 17/2.8 cells by hOP-1. Confluent cells, cultured as described, (28) were treated with doses of hOP-1 eluted from irradiated and nonirradiated hOP-1 devices or with an hOP-1 standard. After removal of culture medium, washed cell layers were sonicated in 500 l of extraction buffer (0.15 M NaCl and 3 mM NaHCO 3 ) containing 1% Triton X-100. Samples were assayed for alkaline phosphatase activity with p-nitrophenyl phosphate as substrate in 0.05 M glycine-NaOH buffer, pH 9.3, and absorbance was measured at 405 nm after stopping the reaction with 100 l of 0.1 M NaOH. (21, 23) The hOP-1 concentrations were based on rpHPLC recoveries, as described in the Materials and Methods section and the Results section.
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the defects. (32) (33) (34) Each source represented a field of 7.84 mm 2 . The cross-sectional area (in mm 2 ) of newly generated bone tissue (mineralized bone, osteoid, and marrow) (36) in each calvarial defect was measured using a computerized image analysis system (Flexible Image Processing System; Council for Scientific and Industrial Research, Pretoria, South Africa) connected to a capturing video-camera (WV-CP410/G Panasonic; Panasonic, Osaka, Japan). (33) Morphometry (volumes and areas) was performed on four sections per implant, representing four parasagittal levels, approximately 2 mm apart from each other. (33) 
Statistical analysis
The data were analyzed with the Statistical Analysis System. (37) An F test was performed using the General Linear Models procedure for an analysis of variance with multiple interactions. (32) Comparison of mean values was obtained using a Duncan's multiple-range test on the dependent variables included in the analysis. The significance probability value associated with the F value for each class variable was accepted as significant at p Ͻ 0.05.
RESULTS
Characterization of the hOP-1 device
The amount of hOP-1 recovered to assess the effect of irradiation of hOP-1 after elution from the 2.5-mg hOP-1 device is shown in Table 1 . Chromatographic profiles obtained from rpHPLC of eluted hOP-1 from nonirradiated and irradiated collagenous matrices indicated that structurally intact hOP-1 could be recovered from hOP-1 devices sterilized by 2.5 Mrads of ␥-irradiation (not shown). The structural integrity of the irradiated and recovered protein was confirmed by SDS/PAGE followed by immunoblot analysis, indicating that gamma irradiation does not significantly alter the immunoreactivity and the electrophoretic mobility of hOP-1 (Fig. 2) . The biological activity of hOP-1 recovered from irradiated and nonirradiated devices was assessed using ROS 17/2.8 cells and induced levels of alkaline phosphatase activity comparable with that of the hOP-1 standard (Fig. 3) . The effect of 2.5 Mrads of ␥-irradiation on the in vivo biological activity of hOP-1 was assessed in the rat subcutaneous assay and the data are summarized in Fig. 4 . Implantation of ␥-irradiated hOP-1 devices resulted in a histologically reproducible pattern of endochondral bone differentiation comparable with that of tissues generated by nonirradiated hOP-1 devices and with comparable tissue alkaline phosphatase activity (Fig. 4A) . ␥-Irradiated specimens yielded less calcium when compared with nonirradiated samples (Fig. 4B ) and contained lower amounts of newly generated cartilage and bone at the lowest dose of irradiated hOP-1 used (Fig. 4C) .
Morphology of calvarial regeneration
Ninety days and 365 days after surgery, untreated defects showed minimal osteogenesis whether adjacent to defects treated with hOP-1 devices or to defects treated with col-
FIG. 4.
In vivo biological activity of nonirradiated and irradiated hOP-1 devices. Doses of hOP-1, combined with 25 mg of bovine collagenous matrix as carrier were sterilized with 2.5 Mrads of ␥-irradiation. Nonirradiated (control) and irradiated hOP-1 devices were implanted in the subcutaneous space of Long-Evans rats at bilateral sites over the pectoralis fascia. Generated tissues were removed on day 12 and subjected to (A) alkaline phosphatase activity and (B) calcium content determination. The alkaline phosphatase activity of the supernatant after homogenization of implants was determined with 0.1 M p-nitrophenyl phosphate as substrate (pH 9.3) at 37°C for 30 minutes. (26) Alkaline phosphatase is expressed as units of activity per milligram protein. Protein concentration in the supernatant was measured by the method of Lowry et al. (49) The calcium content of the acid-soluble fractions of the pellets was determined by colorimetric assay. (14) (C) Newly formed cartilage and bone (%) were examined on 1-m sections stained with toluidine blue after fixation in Bouin's fluid and embedding in Historesin plastic medium (Reichert-Jung). Histomorphometric analysis was as described in the Materials and Methods section for baboon calvarial specimens. Values represent the mean Ϯ SEM of four to five specimens per group; *p Ͻ 0.05 versus nonirradiated specimens.
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lagenous matrix alone (data not shown). On day 90, defects treated with bovine collagenous matrix without OP-1 (control) showed limited bone formation in continuity with the severed calvaria and complete dissolution of the implanted matrix (Fig. 5A ). Defects treated with devices containing 0.1 mg and 0.5 mg hOP-1 resulted in bone regeneration across the defects (Fig. 5B) , although the regenerated bone tissue appeared thinner than the original calvaria (Fig. 5C ). Doses of 2.5 mg hOP-1/g of collagenous matrix induced a more pronounced osteogenic response, with numerous trabeculae covered by continuous osteoid seams facing newly generated marrow (Fig. 5D) . On day 365, devices with 0.1, 0.5, and 2.5 mg hOP-1 induced complete bone regeneration, with reconstruction of the internal and external cortices of the calvaria (Fig. 6 ). Macroscopic examination on day 90 showed areas of ossification beneath the fascia of the temporalis muscle, bilaterally, in animals that were treated in triplicate with the 2.5-mg hOP-1 device. In two animals, discrete flat ossicles, loose beneath the fascia, and ossification along the previously sutured fasciae and underlying muscle were observed. A third animal showed extensive ossification in the form of thick plates of newly formed bone covering almost the entirety of the temporalis muscle, bilaterally (Fig. 7A) . Histological analysis showed formation of cortical and trabecular bone covered by thick osteoid seams (Figs. 7B and  7C ). The finding of heterotopic osteogenesis above the temporalis muscle when the higher dose of the hOP-1 device was used in triplicate in the same animal may be the result of desorption of the recombinant protein from the surface of the carrier matrix, followed by diffusion of hOP-1 along the length of the surgical wound of the temporalis muscle during healing. However, only minor heterotopic flat ossicles were found macroscopically in the fasciae of animals from which tissues were harvested 1 year after the application of the higher dose of hOP-1.
On day 90, 0.1, 0.5, and 2.5 mg of bone-derived baboon BMPs delivered by irradiated bovine collagenous matrix induced new bone formation across the defects (Fig. 8) , with newly formed and mineralized trabeculae being covered by continuous osteoid seams. Defects treated with 0.1 mg and 0.5 mg hOP-1 devices, which were harvested ipsilaterally to the defects treated with bone-derived BMPs, showed bone regeneration comparable with that of the previous series harvested on day 90 (Fig. 8D) .
Morphometry: Effect of hOP-1 and bone-derived BMP doses on bone induction
Volume fractions (with levels of significance) of bone and osteoid in defects treated with the irradiated hOP-1 device are presented in Table 2 . On day 90, 0.1, 0.5, and 2.5 mg hOP-1 devices induced greater amounts of bone and osteoid when compared with irradiated bovine matrix without hOP-1 (control; p Ͻ 0.05, Table 2), with the 2.5 mg dose showing the greater amount of bone when compared with 0.1 mg and 0.5 mg hOP-1 specimens (p Ͻ 0.05, Table  2 ). On day 365, the 0.1-, 0.5-, and 2.5-mg hOP-1 devices 
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showed greater amounts of bone when compared with control (p Ͻ 0.05, Table 2 ). Although doses of 0.1 mg and 0.5 mg hOP-1 generated comparable amounts of bone on day 90, on day 365 greater amounts of bone were found in specimens treated with 0.5 mg hOP-1 (p Ͻ 0.05 vs. 0.1 mg hOP-1, Table 2 ). Histomorphometric data of the present series of 80 calvarial defects were compared with previously published results using identical doses of nonirradiated hOP-1 devices (33) (Table 2) . On day 90, on average, less bone formed in calvarial defects implanted with the irradiated hOP-1 device, including controls (Table 2) . However, osteoid volumes generated by irradiated hOP-1 devices were found to be significantly greater (p Ͻ 0.05 vs. nonirradiated hOP-1, Table 2 ), with the exclusion of the 2.5-mg dose of hOP-1 (6.0 vs. 6.1%, respectively). On day 365, doses of 0.5 mg and 2.5 mg of irradiated hOP-1 showed greater amounts of bone when compared with equivalent doses of hOP-1 delivered by nonirradiated bovine matrix, and with a significant increase in bone volume between day 90 and day 365 (p Ͻ 0.05, Table 2 ).
Volume fractions of tissue components in calvarial defects treated with bone-derived baboon BMPs are shown in Table 3 . Specimens generated by combining doses of baboon BMPs with irradiated bovine collagenous matrix showed substantial osteoid, comparable with osteoid volumes generated by irradiated hOP-1 devices (Table 3) . Doses of 0.1 mg and 0.5 mg of baboon BMPs showed significantly less bone on day 90 when compared with doses of 0.1 mg and 0.5 mg of irradiated hOP-1 devices (p Ͻ 0.05, Table 3 ). The 2.5-mg baboon BMPs, in conjunction with irradiated bovine bone matrix, generated a comparable bone volume with the 2.5-mg hOP-1 device (Tables 2 and 3 ). Separate analysis of the irradiated 0.1-mg and 0.5-mg hOP-1 devices implanted in the two series of animals showed equal or comparable amounts of bone and osteoid volumes (Table 3) . Greater amounts of residual collagenous matrix were found in specimens treated with 0.1 mg and 0.5 mg of baboon BMPs when compared with specimens of hOP-1 devices (Table 3) .
Computer-generated data of cross-sectional areas (in mm 2 ) of specimens treated with the irradiated hOP-1 device on day 90 and day 365 are shown in Fig. 9 . On day 90, irradiated hOP-1 devices generated less bone tissue area when compared with nonirradiated hOP-1 devices (Fig. 9A) . On average on day 90, irradiation of both OP-1 and collagenous matrix resulted in regenerates with reduced tissue area when compared with normal calvaria (mean cross-sectional area, 60.8 Ϯ 3.1 mm 2 ), (33) with the exception of the 2.5-mg dose of irradiated hOP-1 device (Fig. 9A) . On day 365, defects treated with 0.5 mg and 2.5 mg of irradiated hOP-1 devices showed a significant increase compared with day 90 (p Ͻ 0.05), with remodeling that resulted in levels of bone tissue area comparable with normal calvaria (Fig. 9B) . The 0.5-mg dose of hOP-1 showed the highest increase in bone tissue area from day 90 to 365, approaching levels of bone tissue area comparable with the 2.5-mg dose of hOP-1 (Fig. 9B) . 
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DISCUSSION
Information concerning the efficacy of irradiated osteogenic devices in nonhuman primates is an important prerequisite for clinical applications. A series of in vitro and in vivo studies were performed to determine the structural integrity and biological activity of the recoverable hOP-1 after ␥-irradiation before preclinical application in calvarial defects of the adult baboon. Recoveries from rpHPLC and SDS/PAGE and immunoblot analysis indicated that doses of 2.5-3 Mrads of ␥-irradiation did not significantly affect the structural integrity of hOP-1, although less hOP-1 could be recovered from the irradiated collagenous matrix. This possibly reflects some hOP-1 inactivation caused by crosslinking to the collagenous matrix. Biological activity of ␥-irradiated hOP-1 was confirmed in vitro by assessing its induction of alkaline phosphatase activity in ROS cells, and in vivo by evaluating its induction of de novo endochondral bone formation in the subcutaneous space in the rat. Lower doses of ␥-irradiated hOP-1, that is, 0.5 g and 1 g, generated less cartilage and less bone tissue of lower calcium content than nonirradiated controls. A single application of ␥-irradiated recombinant morphogen in conjunction with the xenogeneic bovine collagenous matrix induced regeneration of large calvarial defects of the adult baboon.
Comparison of the data with a previous series of calvarial defects treated with nonirradiated hOP-1 devices prepared with an identical collagenous matrix as carrier (33) showed that ␥-irradiation resulted in reduced bone volume and reduced generated bone tissue area on day 90, as evaluated by histomorphometry. Control specimens of ␥-irradiated collagenous matrix without hOP-1 showed a near 2-fold reduction in osteoconductive bone repair when compared with nonirradiated controls. These data suggest that less bone volume and bone tissue area on day 90 obtained with irradiated hOP-1 devices compared with nonirradiated devices is caused by, at least in part, a reduced performance of the irradiated substratum of the collagenous matrix, although optimal experiments to show this potentially reduced performance would have to be designed to compare the activity of ␥-irradiated hOP-1 delivered by both irradiated and nonirradiated collagenous matrix. The operational reconstitution of a soluble signal (hOP-1) with an insoluble substratum (the collagenous matrix) underscores the critical role of the collagenous matrix for the induction of tissue morphogenesis and regeneration. (1, 7, 25) The importance of 
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the collagenous matrix for cell recruitment, attachment, proliferation, and differentiation has been previously reported. (38, 39) Experiments using ␥-irradiated bone matrices in rodents have indicated that irradiation damages collagen cross-linking, possibly by formation of free radicals, leading to peptide bond cleavage. (40, 41) These changes may affect the instructive role of the substratum in defining the local microenvironment for osteoprogenitor cells proliferation and differentiation. (40) However, it was noteworthy that 1 year after the single application of the ␥-irradiated hOP-1 device, bone and osteoid volumes and generated bone tissue areas were comparable with those of nonirradiated hOP-1 specimens. In particular by 1 year, regenerates induced by 0.5 mg and 2.5 mg of ␥-irradiated hOP-1 induced greater amounts of bone and osteoid volumes when compared with nonirradiated hOP-1. This may be the result of sustained a Doses of hOP-1, combined with 1 g of bovine collagenous matrix as carrier per sample, were subjected to irradiation (2.5 Mrads) and applied once at time of surgery in calvarial defects prepared in 20 adult baboons. Operated sites were harvested on day 90 and day 365 after bilateral carotid perfusion, (27) (28) (29) and serial undecalcified sections, cut at 7 m, were analyzed by histomorphometry. Volume fractions of tissue components (in %) were calculated using a Zeiss Integration Platte II with 100 lattice points superimposed over 5 sources (31) in each of the four saggital sections used for analysis as described in the Materials and Methods section. Corresponding values of bone, osteoid, and matrix volumes (in %) obtained using nonirradiated hOP-1 devices (28) osteogenesis over time in ␥-irradiated specimens as shown by the presence of substantial osteoid volumes on day 90. Doses of 0.1 mg and 0.5 mg of bone-derived baboon BMPs combined with ␥-irradiated bovine collagenous matrix yielded significantly less bone but substantial osteoid volumes when compared with 0.1-mg and 0.5-mg doses of ␥-irradiated hOP-1. Although the partially purified BMP preparation was not subjected to ␥-irradiation, thus precluding a direct comparison with irradiated hOP-1 specimens, it is noteworthy that 2.5 mg of partially purified BMPs and 2.5 mg of hOP-1 delivered by bovine collagenous matrix induced almost identical bone and osteoid volumes by day 90. The hOP-1 specimens (2.5 mg) yielded greater bone tissue area when measured by histomorphometry (data not shown). Partially purified preparations from bone matrix are known to contain, in addition to specific BMPs/OPs, several other proteins and some as yet poorly characterized mitogens. (42) The partially purified preparation from bone matrix obtained using the chromatographic procedures described is known to contain BMP-2, BMP-3, and OP-1 but not detectable TGF-␤s (N.S. Cunningham and A.H. Reddi, unpublished data, 1989). To date, more than 15 related proteins with BMP-like sequences and activity have been cloned, but little is known about their interaction during the cascade of bone formation by induction, or about the biological and therapeutic significance of this apparent redundancy. Recombinantly produced hBMP-2, hBMP-4, and OP-1 are capable of singly initiating bone formation in vivo. (12) (13) (14) It is likely that the endogenous mechanisms of bone repair and regeneration in postnatal life necessitate the deployment and concerted actions of several of the BMPs/OPs resident within the natural milieu of the extracellular matrix of bone. Whether the biological activity of partially purified BMPs is the result of the sum of a plurality of BMP activities or of a truly synergistic interaction among BMP family members deserves appropriate investigation. In addition to bone induction in postfetal life, BMPs/OPs are involved in inductive events that control pattern formation during embryonic morphogenesis and organogenesis in such disparate tissue as the kidney, eye, nervous system, lung, teeth, skin, and heart. (43) These strikingly pleiotropic effects of BMPs/OPs
FIG. 9.
Computerized analysis of new bone tissue area (mineralized bone, osteoid, and marrow) generated by doses of hOP-1 in conjunction with bovine collagenous matrix on (A) day 90 and (B) day 365. Specimens of irradiated hOP-1 device were compared with specimens of nonirradiated hOP-1 device prepared with an identical bovine collagenous matrix. (28) On day 90, doses of 0.1 mg and 0.5 mg of nonirradiated hOP-1 device showed a 2-fold increase in generated bone tissue (p Ͻ 0.05 vs. irradiated hOP-1 device), including collagenous matrix implanted without hOP-1 (A). On day 365, irradiated specimens showed a significant increase over 90 days (p Ͻ 0.05; B), approaching levels of bone tissue area induced by nonirradiated hOP-1 and comparable with the profile of normal unoperated calvaria (inset in A). *p Ͻ 0.05 versus nonirradiated hOP-1 specimens; **p Ͻ 0.05 versus irradiated specimens on day 90. a BMP fractions, purified sequentially by liquid chromatography of guanidinium-extracted proteins from acid-demineralized baboon bone matrix, were combined at doses of 0.1, 0.5, and 2.5 mg with 1 g of ␥-irradiated bovine collagenous matrix as carrier per sample, and after lyophilization, applied to 10 calvarial defects prepared in four adult male baboons. Remaining defects (n ϭ 6) were implanted with 0.1 mg and 0.5 mg of irradiated hOP-1 device. Specimens were harvested on day 90 and serial undecalcified sections were analyzed by histomorphometry as described in the Materials and Methods section. Corresponding morphometric data on day 90 obtained using the 0.1-mg and 0.5-mg hOP-1 doses of the previous experiment (Table 2) 
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may spring from minor amino acid sequence variations in the carboxy-terminal region of the proteins, (44) as well as in the transduction of distinct signaling pathways by individual Smad proteins after transmembrane serine/threonine kinase receptor activation. (45) In conclusion, the present findings illustrate the long-term efficacy of a single application of ␥-irradiated hOP-1 delivered by a xenogeneic collagenous matrix in regenerating large defects of membranous bone of the adult primate. Ultimately, it will be necessary to gain insight into the potentially distinct spatial and temporal patterns of expression of other BMPs/OPs during morphogenesis and regeneration elicited by a single application of hOP-1. In vitro studies indicate that both hOP-1 and hBMP-2 modulate messenger RNA (mRNA) expression of related BMP family members. (46 -48) In vivo studies may be useful in designing therapeutic approaches based on information of gene regulation by hOP-1.
